SCHEMBL2554700

SCHEMBL2554700

Cc1nc(S(=O)(=O)C2CC2)ccc1OC1CCC(OC2CCN(C(C)C)CC2)CC1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 12/20 0.57
HRH3 Q9Y5N1 4/20 0.39
SLC5A7 Q9GZV3 3/20 0.39
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2551083 0.88 GPR119 (0.55) GPR119
SCHEMBL14634432 0.88 GPR119 (0.55) GPR119
SCHEMBL2551086 0.88 GPR119 (0.55) GPR119
SCHEMBL2551264 0.87 GPR119 (0.57) GPR119HRH3SLC5A7CYP1A2
SCHEMBL2554647 0.84 GPR119 (0.82) GPR119
SCHEMBL12284029 0.84 GPR119 (0.82) GPR119
SCHEMBL2557582 0.79 GPR119 (0.47) GPR119HRH3SLC5A7CYP1A2
SCHEMBL2550758 0.78 GPR119 (0.65) GPR119
SCHEMBL2575142 0.78 GPR119 (0.65) GPR119
SCHEMBL2556292 0.76 HRH3 (0.52) GPR119HRH3SLC5A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2556056-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2013-02-13 EP disclosed
WO-2011127051-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2011-10-13 WO disclosed